[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338710-105":59,"doc-detail-338710-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","receipt-of-guideline-concordant-care-and-survival-among-young-adult-women-with-non-metastatic-breast-cancer","Receipt of guideline-concordant care and survival among young adult women with non-metastatic breast cancer","","Purpose focuses on adolescent and young adult (AYA) women with breast cancer, highlighting that they are diagnosed with more aggressive cancers and more advanced stages, leading to poorer survival than older adults. Despite evidence that guideline-concordant cancer care (GCC) improves outcomes, prior research has not assessed how receipt of NCCN-defined GCC affects survival in AYA survivors. The study evaluates the association of GCC with breast cancer-specific survival for young adults aged 20–39.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/receipt-of-guideline-concordant-care-and-survival-among-young-adult-women-with-non-metastatic-breast-cancer/338710/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/receipt-of-guideline-concordant-care-and-survival-among-young-adult-women-with-non-metastatic-breast-cancer/338710.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about guideline-concordant care (GCC)?","Question",{"text":112,"@type":113},"The study examines whether receiving NCCN-defined guideline-concordant care is associated with survival among young adult women (20–39) with non-metastatic breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was guideline-concordant care categorized in the Methods?",{"text":117,"@type":113},"Treatment was categorized as GCC or non-GCC using NCCN guidelines for participants from the Patterns of Care Study, a stratified random sample of 952 women diagnosed in 2013.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the study’s main findings on survival differences?",{"text":121,"@type":113},"Univariate analyses showed non-GCC was associated with worse survival than GCC. The association remained statistically significant in multivariable Cox models for both non-TNBC and TNBC, with effects influenced by sociodemographic and clinical factors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338710,1791295822,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Breast Cancer Research and Treatment (2025) 210:347–354  \n[https://doi.org/10.1007/s10549-024-07570-w](https://doi.org/10.1007/s10549-024-07570-w)  \nReceipt of guideline‑concordant care and survival among young adult women with non‑metastatic breast cancer  \nManami Bhattacharya1,2 · Benmei Liu1 · Allison W. Kurian3 · Jennifer Stevens4 · Lindsey Enewold2 · Dolly C. Penn5,6  \nReceived: 5 September 2024 / Accepted: 22 November 2024 / Published online: 9 December 2024  \nThis is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024  \nAbstract  \nPurpose Adolescent and young adults (AYA) with breast cancer, compared to older adults, are diagnosed with more aggressive cancers, at more advanced stages and may undergo more aggressive treatment but have worse survival. Despite this, no research has studied the effects of the receipt of National Comprehensive Cancer Network (NCCN) defined guidelineconcordant care (GCC) for breast cancer on AYA survival. We examined the association of GCC with survival among young adult (20–39 years old) breast cancer survivors.  \nMethods We used the Patterns of Care Study; a stratified random sample of 952 young adult women diagnosed with Stage I–III breast cancer in 2013. NCCN guidelines were used to categorize treatment as GCC or non-GCC. We used Kaplan–Meier curves, log-rank tests, and Cox-proportional hazards models to evaluate the effect of GCC on breast cancer-specific survival, stratifying by triple-negative breast cancer (TNBC) and non-TNBC, and adjusting for sociodemographic and clinical factors. Results All univariate analyses showed that non-GCC was associated with worse survival than GCC. The association was statistically significant for non-TNBC (Hazard ratio: 3.45, CI 1.64–7.29) and TNBC (Hazard ratio: 3.70, CI 1.02–13.43) in multivariable Cox models adjusted for sociodemographic variables and for non-TNBC (Hazard ratio: 3.13, CI 1.13–8.72) when the model was adjusted for sociodemographic and clinical variables.  \nConclusion Among young adult women with non-metastatic breast cancer, while receipt of NCCN GCC is univariately associated with better survival for both TNBC and non-TNBC, the effect of sociodemographic and clinical factors on the association differs by TNBC status. Further investigation with larger TNBC samples is needed.  \nKeywords Breast cancer · AYA · Guideline-concordant care · Survival · TNBC  \n* Dolly C. Penn [penndc@nih.gov](penndc@nih.gov)  \n1 Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA  \n2 Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA  \n3 Stanford University School of Medicine, Palo Alto, CA, USA  \n4 Information Management Services, Inc, Rockville, MD, USA  \n5 Bethesda Community Clinic, Canton, GA, USA  \n6 Division of Clinical and Health Services Research, National Institute On Minority Health and Health Disparities, National Institutes of Health, 6707 Democracy Boulevard, Suite 800, Bethesda, MD 20892-5465, USA  \nIntroduction  \nBreast cancer accounts for 30% of cancers among adolescent and young adult (AYA) women (15–39 years old) in the United States and is the most common type of cancer diagnosed in this age group [1]. AYA breast cancer is more likely to be diagnosed in advanced stages, with more aggressive subtypes, and is more likely to be associated with inherited genetic mutations [1] . Survival after breast cancer in AYA women tends to be shorter than in other age groups, even accounting for the higher prevalence of worse-prognosis cancer subtypes [2–4] . Prior studies estimate that AYA breast cancer survivors with early-stage disease are 39% more likely to die of their cancer compared to women who are diagnosed later in life [5] .  \nStrategies to improve survival among women of all ages with breast cancer include early detection and ","cbCailZbjEDOr28N","https://ap.wps.com/l/cbCailZbjEDOr28N","pdf",625164,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What question does the study address about guideline-concordant care (GCC)?\",\"answer\":\"The study examines whether receiving NCCN-defined guideline-concordant care is associated with survival among young adult women (20–39) with non-metastatic breast cancer.\"},{\"question\":\"How was guideline-concordant care categorized in the Methods?\",\"answer\":\"Treatment was categorized as GCC or non-GCC using NCCN guidelines for participants from the Patterns of Care Study, a stratified random sample of 952 women diagnosed in 2013.\"},{\"question\":\"What were the study’s main findings on survival differences?\",\"answer\":\"Univariate analyses showed non-GCC was associated with worse survival than GCC. The association remained statistically significant in multivariable Cox models for both non-TNBC and TNBC, with effects influenced by sociodemographic and clinical factors.\"}]","Receipt of guideline-concordant care and survival among young adult women with non-metastatic breast cancer | PDF",1790025194,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3a26d4ec7f7cde0d06b115c974f6561.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4740935fbe7ae83a51716e82299e25a1.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bdf2ccb92a73fad5f5aa7799f71bc00.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdfd1f2919acf010347a55af8f8513dd.webp",980,1301]